This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G, biotin-conjugated
catalog :
MAB858-2B
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
biotin
clone name :
131-2G
application :
immunocytochemistry
citations: 3
Reference |
---|
product information
Catalog Number :
MAB858-2B
Subcategory :
Infectious Diseases
Product Name :
Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G, biotin-conjugated
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Host Name :
Mouse
Antigen :
RSV
Clone :
131-2G
Conjugate :
Biotin
Isotype :
IgG1κ
Product Description :
Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G, biotin-conjugated
Cross Reactivity :
Human
Background :
RSV is a labile paramyxovirus that produces a characteristic fusion of human cells in tissue culture--the syncytial effect. Two subtypes, A and B, have been identified. Subtype B are characterized as the asymptomatic strains of the virus. The more severe clinical illnesses involve Subtype A strains.
ALT Names :
RSV
Immunogen :
A2
Specificity :
Glycoprotein, 89 kD. Recognizes both A and B strains.
Package Size :
100 µg
Uses :
ELISA;Immunofluorescence
Storage :
Maintain at 2 to 8° C in aliquots for up to 12 months after date of receipt. Do not store in diluted format.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments